Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial
Gunst et al., eClinicalMedicine, doi:10.1016/j.eclinm.2021.100849
https://c19early.org/gunst.html